{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-047149","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2024-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.344873+00:00","generated_at":"2026-05-29T20:58:05.204955+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Ensysce stockholders approve reverse stock split authorization and director elections at annual meeting","bullets":["Approved issuance of shares/warrants to investors: 3,102,053 for, 210,141 against (3,995,063 broker non-votes).","Authorized reverse stock split with ratio range 1-for-10 to 1-for-40; board sets exact ratio: 4,561,369 for, 1,989,571 against.","Elected Class III directors Dr. Lynn Kirkpatrick, Dr. Adam Levin, and Mr. Steve Martin (each >2M votes for).","Ratified Moss Adams LLP as auditor for FY 2024: 5,978,860 for, 259,207 against, 1,250,026 abstentions.","Fifth proposal to adjourn meeting if needed was not voted on."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-047149","json":"https://secwatch.observer/filing/0001493152-24-047149.json","markdown":"https://secwatch.observer/filing/0001493152-24-047149.md","text":"https://secwatch.observer/filing/0001493152-24-047149.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315224047149/0001493152-24-047149-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315224047149/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T20:58:05.204955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}